CoChat
Sign Up
Cited by 45

Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis

Medic, Goran, Higashi, Littlewood, Kavi, Diez, Granström, Ola, Kahn·2013·Neuropsychiatric Disease and Treatment
DOI 10.2147/ndt.s39303PMC PMC3552550
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ndt.s39303

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 34

  1. [1]Wu EQ Birnbaum HG Shi L The economic burden of schizophrenia in the United States in 2002 J Clin Psychiatry 2005 66 1122 1129 16187769
  2. [2]Hovinga CA Asato MR Manjunath R Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians Epilepsy Behav 2008 13 316 322 18472303
  3. [3]Baker GA Jacoby A Buck D Quality of life of people with epilepsy: a European study Epilepsia 1997 38 353 362 9070599
  4. [5]Kessler RC Berglund P Demler O The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA 2003 289 3095 3105 12813115
  5. [6]Cramer JA Roy A Burrell A Medication compliance and persistence: terminology and definitions Value Health 2008 11 44 47 18237359
  6. [7]Kelin K Lambert T Jr Brnabic AJ Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence Patient Prefer Adherence 2011 5 213 222 21660103 PMC3105874
  7. [8]Llorca PM Partial compliance in schizophrenia and the impact on patient outcomes Psychiatry Res 2008 161 235 247 18849080
  8. [9]Chen EY Hui CL Dunn EL A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients Schizophr Res 2005 77 99 104 16005389
  9. [10]Eatock J Baker GA Managing patient adherence and quality of life in epilepsy Neuropsychiatr Dis Treat 2007 3 117 131 19300542 PMC2654533
  10. [11]Davis KL Candrilli SD Edin HM Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population Epilepsia 2008 49 446 454 18031549
  11. [12]Ettinger AB Manjunath R Candrilli SD Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy Epilepsy Behav 2009 14 324 329 19028602
  12. [13]Faught E Duh MS Weiner JR Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM study Neurology 2008 71 1572 1578 18565827
  13. [14]Liu X Chen Y Faries DE Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder Clinicoecon Outcomes Res 2011 3 63 72 21935334 PMC3169979
  14. [15]Cramer JA Mattson RH Prevey ML How often is medication taken as prescribed? A novel assessment technique JAMA 1989 261 3273 3277 2716163
  15. [16]Remington G Kwon J Collins A The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia Schizophr Res 2007 90 229 237 17208414
  16. [17]Diaz E Neuse E Sullivan MC Adherence to conventional and atypical antipsychotics after hospital discharge J Clin Psychiatry 2004 65 354 360 15096075
  17. [18]Byerly M Fisher R Whatley K A comparison of electronic monitoring vs clinician rating of antipsychotic adherence in outpatients with schizophrenia Psychiatry Res 2005 133 129 133 15740989
  18. [19]McLaughlin T Hogue SL Stang PE Once-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depression Am J Ther 2007 14 221 225 17414593
  19. [20]Pfeiffer PN Ganoczy D Valenstein M Dosing frequency and adherence to antipsychotic medications Psychiatr Serv 2008 59 1207 1210 18832509
  20. [21]Stang P Young S Hogue S Better patient persistence with once-daily bupropion compared with twice-daily bupropion Am J Ther 2007 14 20 24 17303971
  21. [22]Stang P Suppapanaya N Hogue SL Persistence with once-daily versus twice-daily bupropion for the treatment of depression in a large managed-care population Am J Ther 2007 14 241 246 17515697
  22. [23]Bies RR Gastonguay MR Coley KC Evaluating the consistency of pharmacotherapy exposure by use of state-of-the-art techniques Am J Geriatr Psychiatry 2002 10 696 705 12427578
  23. [24]de Klerk E Patient compliance with enteric-coated weekly fuoxetine during continuation treatment of major depressive disorder J Clin Psychiatry 2001 62 43 47 11599648
  24. [25]Leopold NA Polansky M Hurka MR Drug adherence in Parkinson’s disease Mov Disord 2004 19 513 517 15133814
  25. [26]Bova CA Fennie KP Knaf GJ Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations AIDS Behav 2005 9 103 110 15812617
  26. [27]McKenney JM Munroe WP Wright JT Jr Impact of an electronic medication compliance aid on long-term blood pressure control J Clin Pharmacol 1992 32 277 283 1564133
  27. [28]Shemesh E Non-adherence to medications following pediatric liver transplantation Pediatr Transplant 2004 8 600 605 15598333
  28. [31]Doughty J Baker GA Jacoby A Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy Epilepsy Behav 2003 4 710 716 14698705
  29. [32]Zaccara G Galli A Effectiveness of simplified dosage schedules on the management of ambulant epileptic patients Eur Neurol 1979 18 341 344 527610
  30. [33]Cramer JA Glassman M Rienzi V The relationship between poor medication compliance and seizures Epilepsy Behav 2002 3 338 342 12609331
  31. [34]Meier J Becker T Patel A Effect of medication-related factors on adherence in people with schizophrenia: a European multi-centre study Epidemiol Psichiatr Soc 2010 19 251 259 21261221
  32. [35]Saini SD Schoenfeld P Kaulback K Effect of medication dosing frequency on adherence in chronic diseases Am J Manag Care 2009 15 e22 e33 19514806
  33. [36]Andersson K Melander A Svensson C Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication Eur J Public Health 2005 15 621 626 16126746
  34. [37]Krigsman K Melander A Carlsten A Refill non-adherence to repeat prescriptions leads to treatment gaps or to high extra costs Pharm World Sci 2007 29 19 24 17268941

Cited by

Sorted by citations

Authors
Medic, G., Higashi, Littlewood, K., Diez, Granström, O., & Kahn
Venue
Neuropsychiatric Disease and Treatment
Publisher
Informa UK Limited
Published
2013-01
Pages
119
ISSN
1176-6328
DOI
10.2147/ndt.s39303
PMC
PMC3552550
Cited by
45
References
2
Language
en
Licence
creativecommons.org/licenses/by-nc/3.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review